JEDDAH, Saudi Arabia, Jan. 08, 2026 (GLOBE NEWSWIRE) — As Saudi Arabia continues to build momentum as a premier international destination, Saudia, the Kingdom's national flag carrier, is reinforcing its role as the airline supporting access to the country's most anticipated events throughout 2026. From internationally recognized sporting events and cultural festivals to high-profile business […]
Las Vegas, NV, Jan. 08, 2026 (GLOBE NEWSWIRE) — At CES 2026, Chinese innovator J-STYLE (Jointcorp / Youhong) drew global attention with its latest smart rings, AI smart bands, smart health watches, and biosensors integrated with a remote health management platform, designed for remote health management, corporate wellness, chronic condition monitoring, sports recovery, and insurance
Saudia Continues to Support Saudi Arabia's Expanding Global Events Calendar in 2026 Exciting travel events across Saudi Arabia – including wellness, sports, and music – set the stage for the 2026 travel GlobeNewswire January 08, 2026 JEDDAH, Saudi Arabia, Jan. 08, 2026 (GLOBE NEWSWIRE) — As Saudi Arabia continues to build momentum as a premier
CES 2026 Spotlight: J-STYLE Showcases Smart Wearables and AI Remote Health Management Solutions GlobeNewswire January 08, 2026 Las Vegas, NV, Jan. 08, 2026 (GLOBE NEWSWIRE) — At CES 2026, Chinese innovator J-STYLE (Jointcorp / Youhong) drew global attention with its latest smart rings, AI smart bands, smart health watches, and biosensors integrated with a remote
NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated") (NASDAQ:CORT) concerning potential violations of the federal securities laws. What Happened? • On December 31, 2025, Corcept announced it received a CRL from the FDA, denying
NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Mereo BioPharma Group plc ("Mereo BioPharma Group plc") (NASDAQ:MREO) concerning potential violations of the federal securities laws. On December 29, 2025, before the market opened, Mereo announced results from its Phase 3
Infusion Pump Market is expected to generate a revenue of USD 24.09 Billion by 2031, Globally, at 6% CAGR: Verified Market Research(R) Verified Market Research(R) a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, “Infusion Pump Market Size and Forecast,”. Offering
NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Freeport-McMoRan Inc. (NYSE:FCX) securities. If you suffered a loss on your Freeport-McMoRan Inc. investment and would like to explore a potential
NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Ultragenyx Pharmaceutical Inc. ("Ultragenyx Pharmaceutical Inc.") (NASDAQ:RARE) concerning potential violations of the federal securities laws. What Happened? • On December 29, 2025, Ultragenyx announced the results from both its Phase III Orbit
NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Galectin Therapeutics Inc. ("Galectin Therapeutics Inc.") (NASDAQ:GALT) concerning potential violations of the federal securities laws. Galectin issued a press release on December 19, 2025, "announc[ing] that the U.S. Food and Drug Administration